TROX Tronox Holdings plc
Industrial Inorganic Chemicals · NYSE · SEC CIK 1530804 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY12.0%
TTM net income YoY-55.9%
TTM EPS YoY-55.1%
Revenue 3-yr CAGR4.2%
Net income 3-yr CAGR—
Margins
Gross margin6.8%
Operating margin-5.1%
Net margin-15.9%
FCF margin-0.5%
EBITDA margin3.6%
Returns
ROE-37.6%
ROA-8.3%
ROIC (approx.)-3.0%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets80.4%
Debt / equity2.80x
Current ratio2.52x
Interest coverage-0.75x
Cash quality & payout
Operating cash flow / net income-0.44x
Accruals ratio-11.9%
Payout ratio—
Capex / revenue7.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.90B | $3.07B |
| Gross profit | $269.00M | $515.00M |
| R&D expense | $15.00M | $14.00M |
| SG&A expense | $290.00M | $296.00M |
| Operating income | -$253.00M | $219.00M |
| Interest expense | $189.00M | $167.00M |
| Pretax income | -$458.00M | $73.00M |
| Income tax | $15.00M | $127.00M |
| Net income | -$470.00M | -$48.00M |
| EBITDA | $49.00M | $504.00M |
| EPS (basic) | -2.97 | -0.31 |
| EPS (diluted) | -2.97 | -0.31 |
| Dividends declared per share | 0.35 | 0.50 |
| Weighted avg. shares (diluted) | 158.48M | 157.82M |
| Balance sheet | ||
| Cash & equivalents | $199.00M | $152.00M |
| Receivables | $289.00M | $266.00M |
| Inventory | $1.65B | $1.55B |
| Current assets | $2.27B | $2.15B |
| PP&E, net | $2.01B | $1.93B |
| Intangibles | $214.00M | $244.00M |
| Total assets | $6.22B | $6.04B |
| Current liabilities | $919.00M | $874.00M |
| Short-term debt | $39.00M | $35.00M |
| Long-term debt | $3.13B | $2.76B |
| Total debt | $3.17B | $2.79B |
| Total liabilities | $4.77B | $4.25B |
| Shareholders' equity | $1.42B | $1.76B |
| Net debt | $2.97B | $2.64B |
| Shares outstanding | 158.56M | 157.94M |
| Cash flow statement | ||
| Operating cash flow | $60.00M | $300.00M |
| Capital expenditure | $341.00M | $370.00M |
| Free cash flow | -$281.00M | -$70.00M |
| Investing cash flow | -$328.00M | -$343.00M |
| Financing cash flow | $321.00M | -$71.00M |
| Depreciation & amortization | $302.00M | $285.00M |
| Stock-based compensation | $20.00M | $21.00M |
| Dividends paid | $48.00M | $80.00M |
| Share buybacks | — | $0 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.